Company intelligence / Profile preview

Five Lives

Tours, Centre-Val de Loire, Francefivelives.health ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

Five Lives has developed a direct-to-consumer digital therapeutic mobile app that assesses individual dementia risk using machine learning algorithms and provides personalized interventions across five key lifestyle areas. The product has been launched commercially in the UK and Australia, with ongoing clinical validation studies in partnership with academic institutions such as the University of Oxford. As of late 2022, it had over 25,000 users

Therapeutic areas: Neurology
Modalities: Digital therapeuticNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

University of Oxford (clinical validation)Dementias Platform UK (research collaboration)Partnership with German digital health network "5‑HT" for market access and stakeholder engagement

Beyond the preview

Go deeper on Five Lives.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Five Lives.

Explore the full profile